CVS Health Corporation (CVS) Earnings Call Transcripts

CVS Health Corporation's Latest Earnings Call - Q2 FY2026

In the second quarter of 2026, CVS Health Corporation reported strong financial results, with revenues of over $106 billion and adjusted earnings per share (EPS) of $2.58, reflecting a 40% increase year-over-year. The company raised its full-year adjusted EPS guidance by $0.60 to a range of $7.90 to $8.10 and increased cash flow from operations expectations to at least $11.5 billion, signaling robust operational performance and confidence in future growth. Management emphasized the ongoing success across all operating segments, driven by strategic initiatives and improved consumer engagement.

Reported metrics

Guidance from management

CVS Health raised its full-year 2026 adjusted EPS guidance to a range of $7.90 to $8.10 and increased cash flow from operations expectations to at least $11.5 billion, reflecting strong operational performance and confidence in future growth.

What management said

Thank you, Michael. And I appreciate the comments on the quarter. I'm going to have I'm going to do this in 2 parts. I'm going to have Brian give you kind of the broader financial view of HSS, and then I'm going to have Graham give some color commentary on some of the specifics that you asked. So Brian?

Sure, David. And thanks, Justin. Similar to what we talked about at Investor Day, we're only assuming offsetting dilution in 27, Justin. So nothing beyond that at this point. Obviously, you heard cash is improving. So Prem, do you want to fill in the rest of the color?

What analysts pressed on

Analysts expressed concerns regarding the sustainability of the strong performance in the retail business, particularly with script share gains from Rite Aid that may normalize. There were also inquiries about the impact of the 340B program headwinds and how management plans to mitigate these challenges in 2027.

Main topics on the call

• Revenue Growth Across Segments — CVS Health achieved over $106 billion in revenue, a 7% increase year-over-year, with all operating segments contributing to this growth. Management noted, "each of our operating segments grew earnings and delivered perfo...
• Increased EPS Guidance — The company raised its full-year adjusted EPS guidance by $0.60 to a range of $7.90 to $8.10, reflecting strong performance and confidence in future earnings. This was attributed to a "clear and deliberate enterprise-wid...
• Focus on GLP-1 Therapies — CVS Health is positioning itself as a leader in the GLP-1 weight loss therapy market, offering affordable access through its MinuteClinics and partnerships with manufacturers. They stated, "CVS Health is a leader in all ...
• Technology and AI Investments — Management highlighted significant investments in technology and AI, aiming to enhance operational efficiency and consumer experience. They emphasized a commitment to a "very deliberate and responsible process" in deploy...

Read the full CVS Health Corporation transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 59 CVS Health Corporation earnings call transcripts on record, spanning January 14, 2020 to August 5, 2026. Based on this history, CVS Health Corporation reports quarterly. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

CVS

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

59

First call

January 14, 2020

Most recent

August 5, 2026

Reporting cadence

quarterly